The theranostic optimization of PSMA-GCK01 does not compromise the imaging characteristics of [99mTc]Tc-PSMA-GCK01 compared to dedicated diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in prostate cancer

Mamlins, Eduards; Scharbert, Lara; Cardinale, Jens; Krotov, Maria; Winter, Erik; Rathke, Hendrik; Strodel, Birgit; Ankrah, Alfred O; Sathekge, Mike Machaba; Haberkorn, Uwe; Kratochwil, Clemens; Giesel, Frederik L.

dc.contributor.author	Mamlins, Eduards
dc.contributor.author	Scharbert, Lara
dc.contributor.author	Cardinale, Jens
dc.contributor.author	Krotov, Maria
dc.contributor.author	Winter, Erik
dc.contributor.author	Rathke, Hendrik
dc.contributor.author	Strodel, Birgit
dc.contributor.author	Ankrah, Alfred O
dc.contributor.author	Sathekge, Mike Machaba
dc.contributor.author	Haberkorn, Uwe
dc.contributor.author	Kratochwil, Clemens
dc.contributor.author	Giesel, Frederik L.
dc.date.accessioned	2024-05-10T06:23:15Z
dc.date.available	2024-05-10T06:23:15Z
dc.date.issued	2024-02
dc.description	DATA AVAILABILITY : The data used and/or analyzed during the current study are available from the corresponding author on reasonable request.	en_US
dc.description.abstract	Please read abstract in the article.	en_US
dc.description.department	Nuclear Medicine	en_US
dc.description.librarian	hj2024	en_US
dc.description.sdg	SDG-03:Good heatlh and well-being	en_US
dc.description.sponsorship	Open Access funding enabled and organized by Projekt DEAL. This work was supported by Telix Pharmaceuticals Limited.	en_US
dc.description.uri	https://www.springer.com/journal/11307	en_US
dc.identifier.citation	Mamlins, E., Scharbert, L., Cardinale, J. et al. The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer. Molecular Imaging and Biology 26, 81–89 (2024). https://doi.org/10.1007/s11307-023-01881-y.	en_US
dc.identifier.issn	1536-1632 (print)
dc.identifier.issn	1860-2002 (online)
dc.identifier.other	10.1007/s11307-023-01881-y
dc.identifier.uri	http://hdl.handle.net/2263/95872
dc.language.iso	en	en_US
dc.publisher	Springer	en_US
dc.rights	© The Author(s) 2023. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.	en_US
dc.subject	PSMA-GCK01	en_US
dc.subject	Technetium-99 m	en_US
dc.subject	Single-photon emission computed tomography (SPECT)	en_US
dc.subject	Theranostics	en_US
dc.subject	Prostate cancer	en_US
dc.subject	Prostate-specific membrane antigen (PSMA)	en_US
dc.subject	SDG-03: Good health and well-being	en_US
dc.title	The theranostic optimization of PSMA-GCK01 does not compromise the imaging characteristics of [99mTc]Tc-PSMA-GCK01 compared to dedicated diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in prostate cancer	en_US
dc.type	Article	en_US